Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization

BACKGROUND: Chromogenic in situ hybridization (CISH) is fast becoming a well established technique for easy and sensitive determination of HER2 gene status in breast cancer. However, for the chromogenic method to achieve status as a safe and reliable technique, the method needs to be validated again...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollerup, Jens, Henriksen, Ulla, Müller, Sven, Schønau, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305592/
https://www.ncbi.nlm.nih.gov/pubmed/22333181
http://dx.doi.org/10.1186/1472-6890-12-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305592/
https://www.ncbi.nlm.nih.gov/pubmed/22333181
http://dx.doi.org/10.1186/1472-6890-12-3

Ejemplares similares